EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting CD301+ macrophages inhibits endometrial fibrosis and improves pregnancy outcome

Haining Lv iD, Haixiang Sun, Limin Wang, Simin Yao, Dan Liu, Xiwen Zhang, Zhongrui Pei iD, Jianjun Zhou, Huiyan Wang, Jianwu Dai iD, Guijun Yan, Lijun Ding und 4 weitere

EMBO Molecular Medicine · 11.09.2023 · 15 (9)

DOI: 10.15252/emmm.202317601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EMBO Molecular Medicine, online erschienen am 31.07.2023. Verfasst von Haining Lv und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Pregnancy Outcome, Uterine Diseases. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Biobank of Clinical Resources, MOST | National Natural Science Foundation of China, National Key Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrophages are a key and heterogeneous cell population involved in endometrial repair and regeneration during the menstrual cycle, but their role in the development of intrauterine adhesion (IUA) and sequential endometrial fibrosis remains unclear. Here, we reported that CD301 + macrophages were significantly increased and showed their most active interaction with profibrotic cells in the endometria of IUA patients compared with the normal endometria by single‐cell RNA sequencing, bulk RNA sequencing, and experimental verification. Increasing CD301 + macrophages promoted the differentiation of endometrial stromal cells into myofibroblasts and resulted in extracellular matrix accumulation, which destroyed the physiological architecture of endometrial tissue, drove endometrial fibrosis, and ultimately led to female infertility or adverse pregnancy outcomes. Mechanistically, CD301 + macrophages secreted GAS6 to activate the AXL/NF‐κB pathway, upregulating the profibrotic protein synthesis. Targeted deletion of CD301 + macrophages or inhibition of AXL by Bemcentinib blunted the pathology and improved the outcomes of pregnancy in mice, supporting the therapeutic potential of targeting CD301 + macrophages for treating endometrial fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy OutcomeUterine DiseasesHumansPregnancyFemaleMiceAnimalsEndometriumMacrophagesFibrosis

Stichwörter der Autor:innen

CD301+ macrophagesendometrial fibrosisintrauterine adhesionpregnancy outcome

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
  • Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
  • State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China.

ORCID-Profile: Haining Lv, Zhongrui Pei, Jianwu Dai, Guangfeng Zhao, Yali Hu

Förderung

  • Jiangsu Biobank of Clinical Resources
  • MOST | National Natural Science Foundation of China
  • National Key Natural Science Foundation of China
  • National Key R&D Program of China
  • The Strategic Priority Research Program of the Chinese Academy of Sciences

Zitieren

APA

Lv, H., Sun, H., Wang, L., Yao, S., Liu, D., Zhang, X., Pei, Z., Zhou, J., Wang, H., Dai, J., Yan, G., Ding, L., Wang, Z., Cao, C., Zhao, G., & Hu, Y. (2023). Targeting CD301+ macrophages inhibits endometrial fibrosis and improves pregnancy outcome. EMBO Molecular Medicine, 15(9). https://doi.org/10.15252/emmm.202317601

Vancouver

Lv H, Sun H, Wang L, Yao S, Liu D, Zhang X, et al. Targeting CD301+ macrophages inhibits endometrial fibrosis and improves pregnancy outcome. EMBO Molecular Medicine. 2023;15(9). doi:10.15252/emmm.202317601

BibTeX
@article{Lv2023,
  author = {Lv, Haining and Sun, Haixiang and Wang, Limin and Yao, Simin and Liu, Dan and Zhang, Xiwen and Pei, Zhongrui and Zhou, Jianjun and Wang, Huiyan and Dai, Jianwu and Yan, Guijun and Ding, Lijun and Wang, Zhiyin and Cao, Chenrui and Zhao, Guangfeng and Hu, Yali},
  title = {Targeting CD301+ macrophages inhibits endometrial fibrosis and improves pregnancy outcome},
  journal = {EMBO Molecular Medicine},
  year = {2023},
  volume = {15},
  number = {9},
  doi = {10.15252/emmm.202317601}
}
Kostenlos starten →